Interpace Biosciences, Inc. (IDXG)
USD 1.18
(-8.01%)
USD 1.18
(-8.01%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 23.04 Million USD | 26.39% |
| 2022 | 18.23 Million USD | 1.59% |
| 2021 | 17.94 Million USD | 67.32% |
| 2020 | 10.72 Million USD | 30.94% |
| 2019 | 8.19 Million USD | -29.99% |
| 2018 | 11.69 Million USD | 37.01% |
| 2017 | 8.53 Million USD | 32.51% |
| 2016 | 6.44 Million USD | 155.51% |
| 2015 | 2.52 Million USD | -86.4% |
| 2014 | 18.54 Million USD | -24.04% |
| 2013 | 24.41 Million USD | -9.12% |
| 2012 | 26.86 Million USD | -17.28% |
| 2011 | 32.47 Million USD | 0.83% |
| 2010 | 32.2 Million USD | 22.54% |
| 2009 | 26.28 Million USD | 482.32% |
| 2008 | 4.51 Million USD | -85.73% |
| 2007 | 31.61 Million USD | -43.39% |
| 2006 | 55.84 Million USD | -9.84% |
| 2005 | 61.93 Million USD | -37.33% |
| 2004 | 98.83 Million USD | 10.94% |
| 2003 | 89.08 Million USD | 198.2% |
| 2002 | 29.87 Million USD | -78.0% |
| 2001 | 135.78 Million USD | 18.48% |
| 2000 | 114.6 Million USD | 149.13% |
| 1999 | 46 Million USD | 96.58% |
| 1998 | 23.4 Million USD | 125.0% |
| 1997 | 10.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 6.07 Million USD | -0.62% |
| 2024 Q2 | 7.43 Million USD | 22.4% |
| 2024 Q3 | 7.5 Million USD | 1.01% |
| 2023 Q4 | 6.1 Million USD | 28.48% |
| 2023 Q2 | 6.83 Million USD | 14.34% |
| 2023 Q3 | 4.75 Million USD | -30.43% |
| 2023 Q1 | 5.97 Million USD | 19.3% |
| 2023 FY | 23.04 Million USD | 26.39% |
| 2022 Q4 | 5.01 Million USD | 5.9% |
| 2022 FY | 18.23 Million USD | 1.59% |
| 2022 Q1 | 4.99 Million USD | 12.23% |
| 2022 Q2 | 3.5 Million USD | -29.88% |
| 2022 Q3 | 4.73 Million USD | 35.16% |
| 2021 Q1 | 4.51 Million USD | 44.36% |
| 2021 FY | 17.94 Million USD | 67.32% |
| 2021 Q3 | 3.62 Million USD | -32.32% |
| 2021 Q2 | 5.35 Million USD | 18.55% |
| 2021 Q4 | 4.44 Million USD | 22.76% |
| 2020 Q2 | 1.59 Million USD | -48.3% |
| 2020 Q4 | 3.12 Million USD | 2.46% |
| 2020 Q3 | 3.05 Million USD | 91.35% |
| 2020 Q1 | 3.08 Million USD | 332.81% |
| 2020 FY | 10.72 Million USD | 30.94% |
| 2019 FY | 8.19 Million USD | -29.99% |
| 2019 Q1 | 3.38 Million USD | 4.99% |
| 2019 Q2 | 3.23 Million USD | -4.4% |
| 2019 Q3 | 2.89 Million USD | -10.77% |
| 2019 Q4 | -1.32 Million USD | -145.88% |
| 2018 Q2 | 3.25 Million USD | 45.98% |
| 2018 FY | 11.69 Million USD | 37.01% |
| 2018 Q4 | 3.22 Million USD | 7.93% |
| 2018 Q3 | 2.99 Million USD | -8.11% |
| 2018 Q1 | 2.22 Million USD | -18.38% |
| 2017 FY | 8.53 Million USD | 32.51% |
| 2017 Q4 | 2.73 Million USD | 28.04% |
| 2017 Q3 | 2.13 Million USD | 7.95% |
| 2017 Q1 | 1.69 Million USD | 26.04% |
| 2017 Q2 | 1.97 Million USD | 16.3% |
| 2016 Q2 | 1.77 Million USD | -4.63% |
| 2016 Q1 | 1.85 Million USD | 101.79% |
| 2016 Q4 | 1.34 Million USD | -8.3% |
| 2016 FY | 6.44 Million USD | 155.51% |
| 2016 Q3 | 1.47 Million USD | -16.95% |
| 2015 Q4 | -103.53 Million USD | -1532.06% |
| 2015 FY | 2.52 Million USD | -86.4% |
| 2015 Q1 | 7.64 Million USD | 55.83% |
| 2015 Q2 | 6.09 Million USD | -20.26% |
| 2015 Q3 | 7.23 Million USD | 18.6% |
| 2014 FY | 18.54 Million USD | -24.04% |
| 2014 Q3 | 3.73 Million USD | -22.04% |
| 2014 Q4 | 4.9 Million USD | 31.35% |
| 2014 Q2 | 4.79 Million USD | -6.22% |
| 2014 Q1 | 5.1 Million USD | 16.33% |
| 2013 Q3 | 4.69 Million USD | -31.44% |
| 2013 Q1 | 8.47 Million USD | 21.3% |
| 2013 Q2 | 6.84 Million USD | -19.17% |
| 2013 Q4 | 4.39 Million USD | -6.47% |
| 2013 FY | 24.41 Million USD | -9.12% |
| 2012 Q2 | 6.57 Million USD | -10.81% |
| 2012 Q1 | 7.36 Million USD | 16.46% |
| 2012 Q4 | 6.98 Million USD | 17.61% |
| 2012 FY | 26.86 Million USD | -17.28% |
| 2012 Q3 | 5.93 Million USD | -9.6% |
| 2011 Q3 | 8.17 Million USD | -9.05% |
| 2011 Q2 | 8.98 Million USD | -0.01% |
| 2011 FY | 32.47 Million USD | 0.83% |
| 2011 Q4 | 6.32 Million USD | -22.61% |
| 2011 Q1 | 8.98 Million USD | -5.01% |
| 2010 Q4 | 9.46 Million USD | 11.53% |
| 2010 Q1 | 6.94 Million USD | -8.23% |
| 2010 FY | 32.2 Million USD | 22.54% |
| 2010 Q2 | 8.05 Million USD | 15.99% |
| 2010 Q3 | 8.48 Million USD | 5.29% |
| 2009 Q1 | 4.97 Million USD | 160.72% |
| 2009 Q2 | 6.88 Million USD | 38.42% |
| 2009 FY | 26.28 Million USD | 482.32% |
| 2009 Q3 | 6.85 Million USD | -0.33% |
| 2009 Q4 | 7.56 Million USD | 10.35% |
| 2008 Q1 | 8.69 Million USD | -10.54% |
| 2008 Q4 | -8.18 Million USD | -2087.38% |
| 2008 FY | 4.51 Million USD | -85.73% |
| 2008 Q3 | 412 Thousand USD | -88.52% |
| 2008 Q2 | 3.59 Million USD | -58.73% |
| 2007 Q2 | 7.15 Million USD | -20.32% |
| 2007 Q1 | 8.97 Million USD | -29.77% |
| 2007 FY | 31.61 Million USD | -43.39% |
| 2007 Q4 | 9.72 Million USD | 68.64% |
| 2007 Q3 | 5.76 Million USD | -19.37% |
| 2006 Q3 | 12.4 Million USD | 3.72% |
| 2006 Q4 | 12.77 Million USD | 3.03% |
| 2006 Q2 | 11.95 Million USD | -37.38% |
| 2006 Q1 | 19.09 Million USD | 19.01% |
| 2006 FY | 55.84 Million USD | -9.84% |
| 2005 Q1 | 18.04 Million USD | -30.9% |
| 2005 Q2 | 15.28 Million USD | -15.27% |
| 2005 Q3 | 12.56 Million USD | -17.84% |
| 2005 Q4 | 16.04 Million USD | 27.75% |
| 2005 FY | 61.93 Million USD | -37.33% |
| 2004 Q1 | 26.51 Million USD | -2.15% |
| 2004 Q3 | 24.38 Million USD | 11.78% |
| 2004 FY | 98.83 Million USD | 10.94% |
| 2004 Q4 | 26.11 Million USD | 7.08% |
| 2004 Q2 | 21.81 Million USD | -17.72% |
| 2003 FY | 89.08 Million USD | 198.2% |
| 2003 Q2 | 20.86 Million USD | 18.56% |
| 2003 Q4 | 27.09 Million USD | 15.24% |
| 2003 Q3 | 23.51 Million USD | 12.67% |
| 2003 Q1 | 17.6 Million USD | -30.6% |
| 2002 Q4 | 25.36 Million USD | 972.45% |
| 2002 Q1 | 6.6 Million USD | -83.02% |
| 2002 Q2 | 812 Thousand USD | -87.71% |
| 2002 Q3 | -2.9 Million USD | -458.0% |
| 2002 FY | 29.87 Million USD | -78.0% |
| 2001 Q2 | 39.1 Million USD | -26.85% |
| 2001 Q4 | 38.9 Million USD | 800.44% |
| 2001 Q1 | 53.45 Million USD | 0.31% |
| 2001 Q3 | 4.32 Million USD | -88.95% |
| 2001 FY | 135.78 Million USD | 18.48% |
| 2000 FY | 114.6 Million USD | 149.13% |
| 2000 Q4 | 53.29 Million USD | 146.69% |
| 2000 Q3 | 21.6 Million USD | 19.0% |
| 2000 Q2 | 18.15 Million USD | -15.77% |
| 2000 Q1 | 21.55 Million USD | 55.06% |
| 1999 Q1 | 8.4 Million USD | 40.0% |
| 1999 Q2 | 11.9 Million USD | 41.67% |
| 1999 Q3 | 10.3 Million USD | -13.45% |
| 1999 FY | 46 Million USD | 96.58% |
| 1999 Q4 | 13.9 Million USD | 34.95% |
| 1998 Q2 | 4.4 Million USD | -41.33% |
| 1998 FY | 23.4 Million USD | 125.0% |
| 1998 Q3 | 5.5 Million USD | 25.0% |
| 1998 Q4 | 6 Million USD | 9.09% |
| 1998 Q1 | 7.5 Million USD | -49.66% |
| 1997 Q4 | 14.9 Million USD | 0.0% |
| 1997 Q2 | 14.9 Million USD | 49.0% |
| 1997 Q1 | 10 Million USD | 0.0% |
| 1997 FY | 10.4 Million USD | 0.0% |
| 1997 Q3 | 14.9 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 12039.378% |
| Arrayit Corporation | 2.57 Million USD | -794.854% |
| Atlantic International Corp. | -154.23 Thousand USD | 15040.286% |
| Biocept, Inc. | -2.58 Million USD | 992.448% |
| Bioqual, Inc. | 7.42 Million USD | -210.171% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -8248.913% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.658% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -1184.387% |
| iMD Companies, Inc. | -23.63 Thousand USD | 97586.991% |
| IDenta Corp. | 662.97 Thousand USD | -3375.697% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -29605.689% |
| InVitro International | 635.98 Thousand USD | -3523.199% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -251.105% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -2008.844% |
| NovelStem International Corp. | 12 Thousand USD | -191925.0% |
| Optigenex Inc. | -102.96 Thousand USD | 22479.232% |
| PharmChem, Inc. | 3.9 Million USD | -490.184% |
| Proteome Sciences plc | 2.09 Million USD | -999.049% |
| Response Genetics, Inc | 3.94 Million USD | -484.551% |
| Rennova Health, Inc. | 6.26 Million USD | -267.615% |
| RushNet, Inc. | 1.1 Million USD | -1986.066% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -2590.135% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 5807.287% |
| Todos Medical Ltd. | 4.31 Million USD | -434.64% |